obesity glp-1 news today Use Has More Than Quadrupled Since 2021 as Rates Continue to Show Signs of Decline FDA UPDATE: A new oral

We move beyond the one-size-fits-all model because your health journey is deeply personal

The slim design allows you to store your pens with multiple pen tips while keeping them secure

The findings come amid growing concerns about pet obesity, with an estimated 60% of UK dogs now overweight or obese.[1] The news follows bio-pharma company Okava's plans to trial a weight-loss drug for dogs that mimics the effects of Ozempic, tapping into a potential $10 billion market.[2] Over half of dog owners aged 25-34 are pro "wag-ovy" Research shows that the most receptive group is dog owners aged 2534, with more than half (56%) saying they would be willing to give their pets a vet-recommended GLP-1 injection

Song JY, Lee JS, Wie SH, Kim HY, Lee J, Seo YB, et al

At Genesis Lifestyle Medicine, GLP-1 therapy in Indianapolis is integrated into a personalized, medically supervised plan designed to help you make progress without relying on willpower alone